전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article


References

  1. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. 2006. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev. 28: 112-125.
    Pubmed CrossRef
  2. Roy KM, McMenamin J. 2000. Hepatocellular carcinoma associated with chronic hepatitis B and C: pathogenesis, treatment and prevention. Rev. Med. Microbiol. 11: 171-178.
    CrossRef
  3. Liang TJ. 2009. Hepatitis B: the virus and disease. Hepatology 49: S13-21.
    Pubmed PMC CrossRef
  4. El-Serag HB. 2011. Hepatocellular carcinoma. N. Engl. J. Med. 365: 1118-1127.
    Pubmed CrossRef
  5. Lai C. 2001. Natural history of hepatitis B. Infection 30: 7-12.
  6. Li W, Miao X, Qi Z, Zeng W, Liang J, Liang Z. 2010. Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2. Virol. J. 7: 45.
    Pubmed PMC CrossRef
  7. Brautigam CA, Steitz TA. 1998. Structural and functional insights provided by crystal structures of DNA polymerases and their substrate complexes. Curr. Opin. Struct. Biol. 8: 54-63.
    CrossRef
  8. Hu J, Flores D, Toft D, Wang X, Nguyen D. 2004. Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J. Virol. 78: 13122-13131.
    Pubmed PMC CrossRef
  9. Lund A, Knudsen SM, Vissing H, Clark B, Tommerup N. 1996. Assignment of human elongation factor 1alpha genes: EEF1A maps to chromosome 6q14 and EEF1A2 to 20q13.3. Genomics 36: 359-361.
    Pubmed CrossRef
  10. Sanges C, Scheuermann C, Zahedi RP, Sickmann A, Lamberti A, Migliaccio N, et al. 2012. Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. Cell Death Dis. 3: e276.
    Pubmed PMC CrossRef
  11. Migliaccio N, Sanges C, Ruggiero I, Martucci NM, Rippa E, Arcari P, et al. 2013. Raf kinases in signal transduction and interaction with translation machinery. Biomol. Concepts 4: 391-399.
    Pubmed CrossRef
  12. Hwang YH, Choi JY, Kim S, Chung ES, Kim T, Koh SS, et al. 2004. Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma. Hepatol. Res. 29: 113-121.
    Pubmed CrossRef
  13. Fan Y, Bergmann A. 2008. Apoptosis-induced compensatory proliferation. The Cell is dead. Long live the Cell!. Trends Cell Biol. 18: 467-473.
    Pubmed PMC CrossRef
  14. Adams JM, Cory S. 2007. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr. Opin. Immunol. 19: 488-496.
    Pubmed PMC CrossRef
  15. Veeramah KR, Johnstone L, Karafet TM, Wolf D, Sprissler R, Salogiannis J, et al. 2013. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia 54: 1270-1281.
    Pubmed PMC CrossRef
  16. Miura P, Coriati A, Belanger G, De Repentigny Y, Lee J, Kothary R, et al. 2010. The utrophin A 5'-UTR drives cap-independent translation exclusively in skeletal muscles of transgenic mice and interacts with eEF1A2. Hum. Mol. Genet. 19: 1211-1220.
    Pubmed CrossRef
  17. Lamberti A, Caraglia M, Longo O, Marra M, Abbruzzese A, Arcari P. 2004. The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: Review article. Amino Acids 26: 443-448.
    Pubmed CrossRef
  18. Gandin V, Gutierrez GJ, Brill LM, Varsano T, Feng Y, Aza-Blanc P, et al. 2013. Degradation of newly synthesized polypeptides by ribosome-associated RACK1/c-Jun N-terminal kinase/eukaryotic elongation factor 1A2 complex. Mol. Cell Biol. 33: 2510-2526.
    Pubmed PMC CrossRef
  19. Grassi G, Scaggiante B, Farra R, Dapas B, Agostini F, Baiz D, et al. 2007. The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade. Biochimie 89: 1544-1552.
    Pubmed CrossRef
  20. Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, Toedt G, et al. 2008. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 47: 511-520.
    Pubmed CrossRef
  21. Pellegrino R, Calvisi DF, Neumann O, Kolluru V, Wesely J, Chen X, et al. 2014. EEF1A2 inactivates p53 by way of PI3K/AKT/mTORdependent stabilization of MDM4 in hepatocellular carcinoma. Hepatology 59: 1886-1899.
    Pubmed PMC CrossRef
  22. Abbas W, Khan KA, Kumar A, Tripathy MK, Dichamp I, Keita M, et al. 2014. Blockade of BFA-mediated apoptosis in macrophages by the HIV-1 Nef protein. Cell Death Dis. 5: e1080.
    Pubmed PMC CrossRef
  23. Chang R, Wang E. 2007. Mouse translation elongation factor eEF1A-2 interacts with Prdx-I to protect cells against apoptotic death induced by oxidative stress. J. Cell Biochem. 100: 267-278.
    Pubmed CrossRef
  24. Hanedi A, Burkitt MD, Duckworth CA, Dimaline R, Caamano JH, Pritchard DM. 2012. OC-019 Altered trail, CASPASE12, BAK and FAS-l expressions are associated with increased susceptibility to radiation induced intestinal epithelial apoptosis in NF-κ b1-null and NF-κ b2-null mice. Gut 61: A8-A9.
    CrossRef
  25. Mehmet H. 2000. Caspases find a new place to hide. Nature 403: 29-30.
    Pubmed CrossRef
  26. Hayashi T, Saito A, Okuno S, Ferrand-Drake M, Chan PH. 2003. Induction of GRP78 by ischemic preconditioning reduces endoplasmic reticulum stress and prevents delayed neuronal cell death. J. Cereb. Blood Flow Metab. 23: 949-961.
    Pubmed CrossRef
  27. Meares GP, Zmijewska AA, Jope RS. 2008. HSP105 interacts with GRP78 and GSK3 and promotes ER stress-induced caspase-3 activation. Cell. Signal. 20: 347-358.
    Pubmed PMC CrossRef
  28. Rauschert N, Brändlein S, Holzinger E, Hensel F, Müller-Hermelink H-K, Vollmers HP. 2008. A new tumor-specific variant of GRP78 as target for antibody-based therapy. Lab. Invest. 88: 375-386.
    Pubmed CrossRef
  29. Mcguckin MA, Eri RD, Das I, Lourie R, Florin TH. 2010. ER stress and the unfolded protein response in intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 298: G820-832.
    Pubmed CrossRef
  30. Tian Y, Hu Y, Wang Z, Chen K, Zhang L, Wang L, et al. 2011. Hepatitis B virus regulates Raf1 expression in HepG2.2.15 cells by enhancing its promoter activity. Arch. Virol. 156: 869-874.
    Pubmed CrossRef
  31. Caraglia, M. 2006. Targeting Raf-kinase: molecular rationales and translational issues. Ann. Oncol. 17: vii124-vii127.
    Pubmed CrossRef
  32. Nguyen MH, Trinh HN, Garcia RT, Nguyen LH, Vutien P, Ha NB, et al. 2008. S2075 Prevalence of HBV DNA polymerase (B-DNA Pol) mutations in 345 patients with treatment-Na?Ve chronic hepatitis B (CHB). Gastroenterology 134: Suppl 1. A-310.
    CrossRef

Related articles in JMB

More Related Articles